Sleep, Awake & Move - Part I

CompletedOBSERVATIONAL
Enrollment

67

Participants

Timeline

Start Date

March 16, 2016

Primary Completion Date

May 31, 2019

Study Completion Date

February 9, 2024

Conditions
Idiopathic Parkinson Disease
Trial Locations (1)

6903

Sleep and Epilepsy center Department of Neurology, Neurocenter of Southern Switzerland, Lugano

All Listed Sponsors
collaborator

Parkinson Schweiz

OTHER

collaborator

Ente Ospedaliero Cantonale, Bellinzona

OTHER

collaborator

Penn State University

OTHER

lead

Neurocenter of Southern Switzerland

OTHER

NCT02723396 - Sleep, Awake & Move - Part I | Biotech Hunter | Biotech Hunter